Претраживање
Приказ резултата 51-60 од 60
Parameters of oxidative stress and antioxidative protection in patients with schizophrenia
(Elsevier Science BV, Amsterdam, 2011)
Analysis of interaction between oxcarbazepine and COX-inhibitors in a rat model of inflammatory hyperalgesia
(Elsevier Science BV, Amsterdam, 2010)
Amitriptyline does not potentiate the anti-hyperalgesic effects of gabapentin in a model of painful diabetic neuropathy
(Elsevier Science BV, Amsterdam, 2008)
The involvement of opioidergic receptors in the local peripheral anti-hyperalgesic effect of levetiracetam
(Elsevier Science BV, Amsterdam, 2010)
Antinociceptive effect of levetiracetam in a mouse model of visceral pain
(Elsevier Science BV, Amsterdam, 2011)
Effects of positive alpha5-selective modulation of GABA A receptors on amphetamine-induced hyperlocomotion
(Elsevier Science BV, Amsterdam, 2015)
Quantification of antidepressant and antipsychotic exposure increase caused by CYP2C19 and CYP2D6 intermediate and poor metabolizer status by meta-analysis
(Elsevier, 2019)
Introduction: Most of the antipsychotics and antidepressants are metabolized by CYP2C19 and CYP2D6 enzymes. Both CYP2D6 and CYP2C19 genes are polymorphic and metabolic capacity of the enzymes is genotype-determined. ...
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials
(Elsevier B.V., 2024)
The aim of the study was to assess the clinical utility of currently available pharmacogenomic (PGx) tools compared with treatment as usual (TAU), using a meta-analysis of dichotomous and continuous antidepressant efficacy ...